OpenEvidence hits $12B valuation, with new round led by Thrive, DST
Why it matters
OpenEvidence, a medical information database, has reached a $12 billion valuation after a new funding round led by Thrive and DST, doubling its valuation since October. This achievement comes despite competition from model makers in the industry. The company's growth suggests a strong demand for its services.
Article tone
Neutral
How the article is written, as reported by the source.
Expected market reaction
Market impact analysis based on bullish sentiment with 90% confidence.
Evidence trail
Evidence
Source
TechCrunch
Claim
OpenEvidence hits $12B valuation, with new round led by Thrive, DST
AI inference
Bullish · 90%
Generated
2026-01-21 18:01
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 35450
Original source
The medical info database has doubled in valuation since last raise in October, despite encroachment from model makers.
Read the full article on TechCrunch
Original article published by TechCrunch on January 21, 2026. Analysis and insights provided by AnalystMarkets AI.